Coleen Glessner, EVP of Emergent BioSolutions EBS, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $306.1K. The latest trade was on 06/08.

CG

CG

Coleen Glessner

EVP, Quality & Ethics, and CPL

Company

Emergent BioSolutions EBS

First filing

23/03/06

Trades

27 trades

Buys / sales

0 / 1

12-month net buying

−$306.1K

Last trade

06/08

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Emergent BioSolutionsEBS	Open-market sale	25/10/07	25/10/16	30,608 sh	$10.00	$306,080	−17.5%